SZSaeideh Ziaei

Saeideh Ziaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Saeideh Ziaei has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2009
      • Vol. 15  (1) , CR16-9

    The effect of vitamin E on the treatment of menstrual migraine.

    by Saeideh Ziaei, Anoshirvan Kazemnejad, Akram Sedighi

    Many women with migraine experience a change in migraine frequency associated with the menstrual cycle. This study was undertaken to study the effect of vitamin E as a prophylactic agent on women with menstrual migraine. During a placebo-controlled double-blinded trial, 72 women with menstrual migraine received placebo (identical in appearance to vitamin E) daily for five days, two days before to three days after menstruation for two cycles followed by a one-month wash-out and one vitamin E softgel (400 IU) daily for five days in the next two cycles. Each woman was evaluated monthly throughout the study and the daily headache severity, concomitant symptoms, and functional disability derived from questionnaires were compared between the vitamin E and the placebo treatment periods using four-point anchored scales. There were statistically significant differences in the pain severity and functional disability scales between the placebo and the vitamin E treatments (p<0.001). Vitamin E effect was also superior to placebo regarding photophobia, phonophobia, and nausea (p<0.05). Vitamin E is effective in relieving symptoms due to menstrual migraine.


  • Iron status markers in nonanemic pregnant women with and without iron supplementation

    by Saeideh Ziaei, Maryam Mehrnia, Soghrate Faghihzadeh

    Objective: To measure levels of markers of anemia before and after delivery in women who had high hemoglobin levels during the early stage of the second trimester of pregnancy and did not receive iron supplementation during their pregnancies.Methods: In a randomized, double‐blind, placebo‐controlled trial 244 women who had a hemoglobin concentration of 13.2 g/dL or greater and a serum ferritin level higher than 15 μg/L between the 13th and 18th week of pregnancy took either one 150‐mg tablet of ferrous sulfate daily or placebo during their pregnancies. Markers of anemia were measured at the time of delivery and 6 weeks postpartum.Results: There were statistically significant differences between the 2 groups in hematocrit as well as hemoglobin and ferritin levels both at the time of delivery and 6 weeks postpartum (P < 0.05), but these differences were not clinically significant.Conclusion: Not using iron supplementation did not cause a considerable decrease in markers of anemia in women with a hemoglobin concentration of 13.2 g/dL or greater in the second trimester of pregnancy.


  • The effects of iron supplementation on serum copper and zinc levels in pregnant women with high‐normal hemoglobin

    by Saeideh Ziaei, R. Janghorban, Sosan Shariatdoust, Sofhrate Faghihzadeh

    Objective: To evaluate the effect of iron supplementation on serum copper and zinc levels.Method: In a randomized, double‐blind, placebo‐controlled trial, 66 pregnant women with hemoglobin 13.2 g/dL or greater between the 13th and 18th week of pregnancy were randomized into case and control groups. From the 20th week until the end of pregnancy the case group received one ferrous sulfate tablet containing 50 mg elemental iron daily, while the control group received placebo. Hemoglobin, ferritin, copper, and zinc levels at 24‐28 and 32‐36 weeks of pregnancy were measured and compared.Results: In the case group, serum copper levels in the second and third trimester were significantly lower than the control group (P < 0.01 and P < 0.001, respectively). Serum zinc levels in the case group in the second and third trimester were also significantly lower than the control group (P < 0.001).Conclusion: Iron supplementation in pregnant women with hemoglobin greater than 13.2 g/dL reduces serum levels of copper and zinc.


  • The Effect of Vitamin E on Hot Flashes in Menopausal Women

    by S. Ziaei, A. Kazemnejad, M. Zareai

    Background: Hot flashes affect as many as 75% of menopausal women. Estrogen reliably reduces the severity of hot flashes and remain the single most effective treatment. Today, however, more and more women are seeking alternatives. Instead of hormonal therapy, women are turning to vitamins, and other over-the-counter products for relief from hot flashes. This study was undertaken to assess the effect of vitamin E on hot flashes. Method: A placebo double blind-controlled trial was conducted. After 1 week baseline period, the enrolled patients (n = 51) received placebo (identical in appearance to vitamin E softgel) daily for 4 weeks, followed by 1 week wash out and 400 IU vitamin E (softgel cap) daily for the next 4 weeks. Diary was used to measure hot flashes before and at the end of the study. Result: There were statistical significant differences in hot flashes severity score (2.37 ± 0.74, 1.80 ± 0.87) and their daily frequency (5.00 ± 3.34, 3.19 ± 2.74) after the treatments between the placebo and vitamin E therapies (p < 0.0001). Conclusion: Based on our trial, vitamin E is recommended for the treatment of hot flashes.


  • Open Access

    A randomised placebo‐controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl

    by S Ziaei, M Norrozi, S Faghihzadeh, E Jafarbegloo

    Objective  To study the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin (Hb) ≥13.2 g/dl.Design  A randomised, double‐blind, placebo‐controlled trial.Setting  Routine health services.Population  Seven hundred and twenty‐seven pregnant women with Hb ≥13.2 g/dl in the early stage of the second trimester.Methods  Each woman took one tablet of 50 mg of ferrous sulphate daily in the case group (n = 370) or placebo in the control group (n = 357) throughout pregnancy.Main outcome measures  Pregnancy outcome.Results  While there were no significant differences in demographic and obstetric characteristics between the two groups before any intervention, small‐for‐gestational‐age birth rate and the number of women with hypertension disorder increased significantly in the case group in comparison with the control group (57 [15.7%] versus 36 [10.3%], P = 0.035, 10 [2.7%] versus 3 [8%], P = 0.05, respectively).Conclusions  Our finding proves that routine iron supplementation in nonanaemic women is not rational and may be harmful.


  • Effect of Bacterial Vaginosis on Premature Rupture of Membranes and Related Complications in Pregnant Women with a Gestational Age of 37–42 Weeks

    by Saeideh Ziaei, Mitra Sadrkhanlu, Ashraf Moeini, Soghrate Faghihzadeh

    Background: The most serious outcome of term, premature rupture of membrane and chorioamnionitis is often associated with adverse maternal and infant outcomes related to infection. This study was undertaken to determine the prevalence of bacterial vaginosis (BV) at 37–42 gestational weeks and its relationship to premature rupture of membranes. Method: During an analytical descriptive prospective study, 425 pregnant women with a gestational age of 37–42 weeks were studied for prevalence of BV. Then, 304 women on the basis of having BV or not were followed up until 48 h after delivery for premature rupture of membranes. Result: The rate of BV in this population was 30.5%. No significant association was found between BV and premature rupture of membranes (odds ratio 1.6, 95% CI 0.9–2.8).Conclusion: BV is a common vaginitis in term pregnancy, but we could not find any relationship between BV and premature rupture of membranes at term.


  • Serum Lipid Levels at 28–32 Weeks Gestation and Hypertensive Disorders

    by Saeideh Ziaei, Khayyati Motlagh Bonab, Anoshirvan Kazemnejad

    Background: The etiology and pathogenesis of hypertensive disorders complicating pregnancy are poorly understood, and the definition of these disorders is controversial. Methods: In a prospective study, 470 primigravida women between 28 and 32 weeks of pregnancy were evaluated for serum levels of total cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, and triglyceride. Afterward, they were observed for any symptoms of preeclampsia and gestational hypertension until 40 weeks of gestational age. We than compared the serum lipid levels among women with preeclampsia and gestational hypertension with those of matched women with normal pregnancies. Results: The numbers of patients developing preeclampsia and gestational hypertension were 25 (5.3%) and 32 (6.8%), respectively. At the beginning of the study, the mean values of serum triglyceride levels between women who later experienced preeclampsia or gestational hypertension and those who did not differed significantly (p < 0.0001, p < 0.03). Conclusion: Although many cases of gestational hypertension represent latent essential hypertension based on the lipid levels, some of these women display true pregnancy-induced hypertension or nonproteinuric preeclampsia.


  • Relationship between β-hCG levels in cervicovaginal secretions and labor

    by S. Ziaei, A. Bahadori, S. Faghihzadeh

    To determine whether levels of human beta-chorionic gonadotropin hormone (beta-hCG) in cervicovaginal secretions can predict the labor process. A total of 150 women admitted in active labor to the urgent delivery unit of a university hospital were enrolled in a prospective study. The beta-hCG level of each woman's cervicovaginal secretions was measured by radioimmunoassay on admission; then, beta-hCG levels were compared between 2 groups of 35 women, one in whom labor progressed normally and another in whom augmentation of labor with oxytocin was required. There were significant differences in beta-hCG levels of cervicovaginal secretions between the spontaneous delivery group and the augmentation of labor group (130.72+/-64.51 mU/mL vs. 93.9+/-65.29 mU/mL) (P<0.05). A receiver-operating characteristic (ROC) curve analysis showed that the optimal cut-off value was 82 mU/mL, with a sensitivity of 66% and a specificity of 60%. beta-chorionic gonadotropin hormone levels were significantly higher in the cervicovaginal secretions of women whose labor was progressing normally than in those who required augmentation of labor.


  • Effects of carbon monoxide air pollution in pregnancy on neonatal nucleated red blood cells

    by Saeideh Ziaei, Kobra Nouri, Anoshirvan Kazemnejad

    Summary: In an analytical cross‐sectional study, the effects of carbon monoxide air pollution on carboxyhaemoglobin (COHb) and absolute nucleated red blood cells (nRBC) of the cord venous blood, were evaluated in 41 newborns delivered by caesarean section at term to mothers who had lived in an air‐polluted area in the centre of Tehran during their pregnancies (study group). The parameters used were compared with 32 cord venous bloods of term caesarean‐delivered newborns of mothers living in a healthy air area outside the city during their pregnancies.A significant difference was observed between the two groups in the cord COHb levels (mean ± SD 10.51 ± 4.79 vs. 1.58 ± 0.96, P < 0.001), cord nRBC (723.87 ± 275.23 × 106/L vs. 248.44 ± 160.79 × 106/L, P < 0.001). A significant correlation was found between ambient carbon monoxide and cord COHb in the study and control groups, respectively (r = 0.863, P = 0.0001; r = 0.691, P = 0.0001), and also cord COHb and cord nRBC in the study group (r = 0.360, P = 0.01).Neonates born to mothers exposed to carbon monoxide air pollution had increased circulating absolute nRBC counts compared with those of the control group. We speculate that air pollution exposure in pregnancy should be avoided, because it may have negative effects on fetal oxygenation.